Training Example: Vafseo (Akebia Therapeutics, Inc.) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

Vafseo (Akebia Therapeutics, Inc.)

(https://vafseo.com) 📸 Data Snapshot: May 26, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Vafseo® (vadadustat) | Patient Info (https://vafseo.com)
Title

Vafseo® (vadadustat) | Patient Info

H1 Vafseo (VAFF-see-oh) is a once-daily oral pill to treat anemia caused by chronic kidney disease (CKD) in adults on dialysis for at least 3 months. And it's injection free.
H2 what is Vafseo?
H2 taking Vafseo
H2 support
H3 How does it work?
H3 How should I take Vafseo?
H3 What are the possible side effects of Vafseo?
H3 Questions about AkebiaCares support?
H3 IMPORTANT SAFETY INFORMATION about VAFSEO (vadadustat)
H3 APPROVED USE
H3 APPROVED USE AND SAFETY INFORMATION for VAFSEO (vadadustat)
H3 IMPORTANT SAFETY INFORMATION about VAFSEO (vadadustat)
H4 Vafseo is taken:
H4 APPROVED USE
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://vafseo.com) Vafseo® (vadadustat) | Patient Info
[IMG: Scroll]
Scroll
[H1]
Vafseo (VAFF-see-oh) is a
once-daily oral pill
to
treat anemia caused by chronic kidney disease (CKD) in
adults
on dialysis for at least 3 months. And it's
injection free.
Download the Medication Guide Download the Medication Guide
[H2]
what is
Vafseo?

Vafseo is a prescription medicine used to treat anemia caused by CKD
in adults on dialysis for at least 3 months. Vafseo is taken orally
(by mouth) once a day.
Vafseo has not been proven to improve quality of life, tiredness
(fatigue), or well-being.
Vafseo should not be used in place of emergency treatment for
anemia, such as red blood cell (RBC) transfusions or for the
treatment of anemia that is caused by CKD in people who are not on
dialysis.
[H3] How does it work?
People with anemia have a lower-than-normal number of RBCs. RBCs
contain hemoglobin, which carries the oxygen your body needs. Fewer
red blood cells can result in less hemoglobin, which means there is
not enough oxygen to help your tissues and organs work properly.
Vafseo works by increasing a protein called erythropoietin
(pronounced “eh-ri-thruh-poi-e-tin”). Erythropoietin helps your body
make more RBCs.
This increase in RBCs means there is more hemoglobin to carry oxygen
throughout your body.
[H2] taking Vafseo
[H3] How should I take Vafseo?
[H4] Vafseo is taken:
Once-a-day
orally
At a time that works for you,
as directed by your doctor
Separately from oral iron
or phosphate binders
Take Vafseo exactly as your healthcare provider tells you to take
it. Do not change your dose unless your healthcare provider tells
you to.
Important reminders when taking Vafseo 1.
Vafseo should be swallowed whole. It should not be cut, crushed, or chewed
2.
To ensure Vafseo works properly, avoid taking it at the same
time as iron supplements, products containing iron, or
phosphate binders
Take Vafseo at least 1 hour before taking iron supplements, products containing iron, or phosphate binders that contain iron
Take Vafseo at least 1 hour before or 2 hours after taking phosphate binders that do not contain iron
3.
Missed a Vafseo dose? Take it when you remember on the same day.
Continue with your usual schedule the next day
4.
Do not take more than one dose a day. Tell your healthcare
provider right away if you take more than your prescribed dose
of Vafseo
[H3] What are the possible side effects of Vafseo?
Vafseo may cause serious side effects including an increased
risk of death, heart attack, stroke, and blood clots.
Vafseo may cause other serious side effects,
including: Liver problems High blood pressure Seizures
Damage, such as ulcers, to the lining of the esophagus, stomach, or intestines (gastrointestinal erosion)
Cancer
The most common side effects of Vafseo include:
High blood pressure Diarrhea
These are not all the possible side effects of Vafseo. Call your
doctor for medical advice about side effects. You may report
side effects to Akebia Therapeutics, Inc. at
1‑844‑445‑3799
or to FDA at
1‑800‑FDA‑1088
or
www.fda.gov/medwatch.
[H2] support
[IMG: AkebiaCares]
[H3] Questions about AkebiaCares support?
AkebiaCares Case Managers are standing by live to answer your call.
1‑855‑686‑8601
Monday - Friday | 8AM - 8PM
ET Ask your doctor how Vafseo can help you
[H3]
IMPORTANT SAFETY INFORMATION
about VAFSEO (vadadustat)

MOST IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT VAFSEO
VAFSEO may cause serious side effects, including:
Increased risk of death, heart attack, stroke, and blood clots.
These risks may happen if you are treated with VAFSEO to
increase red blood cells (RBCs) to near the same level found
in healthy people. These risks may be increased if you have
heart or blood vessel problems, or problems with blood flow
to your brain. Blood clots can form in the blood vessels,
including your legs, lungs, and in your dialysis access.
Get medical help right away if you get any of the following signs or symptoms:
chest pain; trouble breathing or shortness of breath; cold
sweat; sudden numbness or weakness in your face, arm or leg,
especially on one side of your body; sudden confusion,
trouble speaking, or trouble understanding others’ speech;
sudden trouble seeing; sudden trouble walking, dizziness,
loss of balance or coordination; loss of consciousness
(fainting); severe headache; pain in your legs, with or
without swelling; a cool or pale arm or leg; changes to your
dialysis access site, including swelling or discoloration
near the site; do not feel a vibration (“thrill”) over the
dialysis access area.
If you decide to take VAFSEO, your healthcare provider
should prescribe the lowest dose of VAFSEO that is necessary
to reduce your chance of needing red blood cell
transfusions.
DO NOT USE VAFSEO IF YOU:
are allergic to vadadustat or any of the ingredients in VAFSEO. Refer to the Medication Guide for a complete list of ingredients in VAFSEO. have high blood pressure that is not controlled (uncontrolled hypertension). WARNINGS VAFSEO may cause other serious side effects, including: Liver problems. VAFSEO may cause changes in
blood liver tests, which may be a sign of liver injury. Your
healthcare provider will do blood liver tests before
starting treatment with VAFSEO, monthly for the first 6
months and then as needed. Your healthcare provider may stop
treatment with VAFSEO if you have changes in your blood
liver tests. Tell your healthcare provider if you
experience: tiredness; loss of appetite; pain in your right
upper stomach area (abdomen); dark urine; yellowing of your
skin or the white part of your eyes.
High blood pressure. VAFSEO may cause you
to develop new or worsening high blood pressure. Monitor
your blood pressure regularly, follow any instructions from
your healthcare provider about controlling your blood
pressure, and tell your healthcare provider about any
changes.
Seizures. Seizures have happened in people
treated with VAFSEO. Tell your healthcare provider about new
onset of seizures, change in how often you have seizures, or
if you experience signs or symptoms that a seizure may
happen: headache, irritability, fear, confusion, or unusual
feelings.
Damage to the lining of the esophagus, stomach, or intestines (such as ulcers).
Your risk of damage to the lining of the esophagus, stomach,
or intestines may increase if you have a prior history,
stomach ulcers (peptic ulcer disease), use certain medicines
that increase the risk of damage, or currently smoke tobacco
or drink alcohol. Get medical care right away if you
experience stomach-area (abdominal) discomfort or pain;
nausea or vomiting; blood in your vomit or stool; black,
tarry stools; trouble swallowing; pain in your throat or
chest.
Cancer. Cancers have happened in people
treated with VAFSEO. Talk to your healthcare provider if you
have any concerns about cancer.
Ask a healthcare provider before use if you:
have heart disease. have had a stroke. have liver problems. have high blood pressure. have had a seizure. have a history of damage, such as ulcers, to the lining of the esophagus, stomach, or intestine. smoke tobacco or drink alcohol. have cancer. are pregnant or plan to become pregnant. Pregnancy Exposure Registry: If you take VAFSEO during pregnancy, you can enroll in a registry that collects information about your health and your baby’s health. For more information or to report a pregnancy, call 1‑844‑445‑3799. are breastfeeding or plan to breastfeed. Do not breastfeed during treatment with VAFSEO and for 2 days after your final dose.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your healthcare provider if you take
iron supplements, products containing iron or
phosphate binders by mouth. These products affect
how VAFSEO works and should not be taken at the same
time you take VAFSEO. Ask your healthcare provider
if you are not sure if you take any of these products.
WHEN USING VAFSEO, YOU MAY HAVE high blood pressure diarrhea
The risk information provided here is not complete. To
learn more, talk about VAFSEO with your healthcare
provider. The FDA-approved product labeling, including
BOXED WARNING and Medication Guide can be found
here.
You are encouraged to report negative side effects of
prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call
1-800-FDA-1088.
[H3]
APPROVED USE

VAFSEO (vadadustat) is a prescription medicine used to treat
anemia caused by chronic kidney disease (CKD) in adults who have
been on dialysis for at least three months.
VAFSEO has not been proven to improve quality of life, tiredness
(fatigue), or well-being.
VAFSEO should not be used:
in place of emergency treatment for anemia (red blood cell transfusions). for the treatment of anemia that is caused by CKD in people who are not on dialysis.
8996 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
0Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: Vafseo (Akebia Therapeutics, Inc.) (vafseo.com)

https://vafseo.com 📍 Industry: Medical Devices, Pharma & Biotech
14 BS / 100

This site is a rare example of a low-BS environment, largely due to the iron grip of FDA regulatory requirements. It prioritizes risk disclosure and specific mechanical explanations over marketing hyperbole. The BS score is driven only by technical gaps in structured data and the absence of direct links to primary clinical research in the crawl.

Info Density Power-words vs. Substance ratio.
2
7% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
1
5% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
4
20% BS
Commodity Fingerprint Detection of industry clichés/templates.
2
13% BS
Identity & Authority Expert verifiability & Schema depth.
5
33% BS

Implement Organization and MedicalWebPage schema to technically validate the brand authority. Add a dedicated ‘Clinical Evidence’ section that links directly to the peer-reviewed publications in The New England Journal of Medicine or similar, rather than just the Medication Guide. Ensure the ‘AkebiaCares’ section includes a specific ‘Post-Market Surveillance’ tag to satisfy pharmacovigilance proof expectations. Replace generic images with specific molecular diagrams or clinical chart summaries to further increase proof density.

The site content perfectly aligns with the Medical, Pharma & Biotech industry, specifically the pharmaceutical sub-sector. The presence of extensive Important Safety Information (ISI), Boxed Warnings, and specific mechanism of action descriptions (erythropoietin) confirms its role as a regulated drug information portal.

“The score of 14 is exceptionally low, indicating high substance. The score was primarily influenced by Identity and Authority (5 points) due to missing schema and Trust and Proof (4 points) due to the lack of direct external study links. Information Density (2 points) and Commodity Fingerprint (2 points) were near zero, reflecting the absence of standard marketing fluff.”

Verified Analysis Date: May 26, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Brand AI Reputation